Related Experiment Videos
[Carcinosarcoma of the prostate. Case report]
A Benchekroun1, A Lachkar, A Soumana
1Clinique Urologique A, CHU Ibn Sina, Rabat, Maroc.
Annales D'Urologie
|October 8, 1999
Summary
This case report details a rare prostatic carcinosarcoma in a 43-year-old male. Despite VAC chemotherapy, the aggressive cancer led to a fatal outcome within two months.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Prostatic carcinosarcoma is an extremely rare and aggressive malignancy.
- Early diagnosis and effective treatment remain challenging due to its rarity.
Observation:
- A 43-year-old male presented with urinary symptoms, lower limb edema, and general malaise.
- Physical examination revealed a large, hard, irregular prostate with elevated prostate-specific antigen (PSA) levels.
- Imaging confirmed a bulky, heterogeneous 11 cm mass invading the bladder base and pelvic muscles.
Findings:
- Histological analysis of the mass revealed a biphasic tumor comprising adenocarcinoma and a mesenchymal component, consistent with prostatic carcinosarcoma.
- The patient received VAC chemotherapy (Vincristine, Dactinomycin, Cyclophosphamide).
Implications:
- This case highlights the aggressive nature of prostatic carcinosarcoma and the limited treatment options.
- Further research into the pathogenesis and novel therapeutic strategies for this rare tumor is warranted.